Hot Deals:
adtech 73.00 (1.39 %) agarwal bolts 1,200.00 (0.00 %) amol minechem 601.00 (0.17 %) anand i-power 20.00 anglo french drugs 745.00 (-0.67 %) apl metals 40.00 (-2.44 %) arkfin investments 50.00 arohan 150.00 (3.45 %) assam carbon 215.00 (2.38 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) av thomas 16,800.00 (0.00 %) axles 500.00 (2.04 %) balmer lawrie 202.00 (1.00 %) bharat hotels 300.00 (3.45 %) bima mandi 235.00 (-2.08 %) bira 600.00 (0.84 %) boat 1,350.00 (1.50 %) c & s electric 600.00 (1.69 %) cable corporation 13.00 (-0.76 %) capgemini 11,500.00 (0.88 %) care health 179.00 (-0.56 %) carrier aircon 535.00 (1.90 %) cial 285.00 (1.79 %) csk 183.00 (-0.54 %) dalmia refract 195.00 (2.63 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 425.00 (2.66 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,050.00 (-0.97 %) esl steel 45.00 (2.27 %) fincare business 72.00 (2.86 %) fincare sfbl 202.00 (1.00 %) finopaytech 156.00 (0.65 %) flipkart india 231,001.00 (0.00 %) frick india 15,800.00 (3.95 %) gkn driveline 1,350.00 (3.05 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) goodluck defence 240.00 (-1.23 %) group pharma 300.00 gynofem healthcare 81.00 (1.25 %) hdb financial 1,050.00 (5.53 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,000.00 (1.85 %) hella india 810.00 (1.25 %) hero fincorp 1,685.00 (-0.12 %) hexaware 885.00 (0.57 %) hicks 1,450.00 (2.11 %) hira ferro 155.00 (3.33 %) honeywell electrical 4,500.00 (2.27 %) ikf finance 243.00 (1.25 %) incred financial 109.00 (3.81 %) incred holdings 151.00 (0.67 %) india carbon 1,175.00 (0.43 %) india exposition 140.00 (3.70 %) indian potash 2,900.00 (-1.69 %) indo alusys 25.75 (-0.96 %) indofil 790.00 (-1.25 %) infinite computer 405.00 (1.25 %) inkel 21.50 (2.38 %) ixigo 143.00 (-1.38 %) jana small finance bank 75.00 kel 625.00 (1.63 %) kial 122.00 (-2.40 %) klm axiva 15.00 (-1.32 %) kurlon limited 1,250.00 (2.46 %) lava 70.00 (-1.41 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 1,333.00 (-1.26 %) martin & harris 1,020.00 (0.99 %) merino 3,250.00 (1.56 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 421.00 (-0.94 %) mobikwik 570.00 (-0.87 %) mohan meakin 1,950.00 (2.63 %) mohfl 12.80 (-1.54 %) msei 1.14 (-0.87 %) msil 35.00 (-2.78 %) nayara energy 480.00 (1.05 %) nayara energy ncd 285.00 (1.79 %) ncdex 275.00 ncl buildtek 260.00 (1.56 %) ncl holdings 85.00 (3.66 %) nsdl 777.00 (3.60 %) nse 4,500.00 (-0.99 %) orbis financial 280.00 (1.82 %) oswal minerals 60.10 (-1.48 %) otis 3,770.00 (0.53 %) oyo 55.00 (-1.79 %) panasonic appliances 211.00 (0.48 %) paymate india 514.00 (-0.19 %) pharmeasy 10.00 (1.01 %) pharmed limited 480.00 (2.13 %) philips domestic 600.00 (1.69 %) philips india 920.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 275.00 (-1.79 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 480.00 (1.05 %) resins plastics 415.00 (-1.89 %) ring plus aqua 530.00 (0.95 %) rrl 1,275.00 (2.00 %) rrp s4e innovation 282.00 (0.71 %) sab miller 375.00 (-1.32 %) sbi amc 1,670.00 (1.21 %) sbi general insurance 600.00 (3.45 %) scottish assam 440.00 (-1.35 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,400.00 (3.70 %) smile microfinance 54.00 (3.85 %) sportskeeda 3,303.00 sterlite power 522.00 (-0.57 %) studds 975.00 (0.52 %) svsml 315.00 (2.94 %) swiggy 345.00 (-1.43 %) t stanes 770.00 (1.99 %) tata capital 920.00 (2.22 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,290.00 (-0.77 %) urban tots 52.00 (4.00 %) utkarsh coreinvest 285.00 (-1.72 %) vadilal dairy 10.00 vikram solar 230.00 (-4.17 %) waree energies 1,880.00 (1.62 %)
×

Claris Life Sciences Share Price

Claris Life Sciences Limited Fundamentals

Company Name
Claris Life Sciences Limited
Scrip Name
Claris Life Sciences
Last Traded Price
1.00
-99.60 %
Sector
Pharma
PAN No.
AAACC6366Q
Face Value
10
No. of Outstanding Shares
54,567,765
EPS
-0.05
PE ratio
-
Market Capitalization
5.46 Crore
Book value
-2.137
P/BV
-
ISIN No.
INE562G01018
Available on
nsdl
ROFR Require
No
Day High
1.00
Day Low
1.00
52 Week High
1.00
52 Week Low
1.00
Lifetime High
250.00
Lifetime Low
1.00

Claris Life Sciences Price Performance

CLARIS LIFESCIENCES LIMITED DELISTED/UNLISTED SHARES - Company Overview

Founded on 19 July 1994, Claris Lifesciences Limited is a Public Limited Company it is involved in Human Healthcare Activities. It is registered at the registrar of companies in Ahmedabad.  The authorized equity capital of the company is Rs. 1,205,100,030 and the paid-up capital is Rs. 545,677,630.

Shares of Claris Lifesciences Limited were listed on the BSE.  The company's shares stopped trading on BSE on March 15, 2018, and it was delisted from the BSE on March 22, 2018. The exit offer price was Rs. 400 per share for public shareholders.

Claris Life Sciences Limited Details as of March 31, 2022

Claris Life Sciences Outstanding Shares:

                                                                   54,567,765

Face Value of Claris Life Science Unlisted Share:

Rs. 10 Per Equity Shares

ISIN of Claris Life Sciences Limited Unlisted Share:

INE562G01018

Lot Size of Claris Life Sciences Unlisted Share:

100 Shares

Claris Life Sciences Limited Share Price:

Best in Industry

PAN Number of Claris Life Sciences:

AAACC6366Q

Incorporation Details of Claris Life Sciences Limited

Claris Life Sciences CIN Number

 U85110GJ1994PLC022543 

Claris Life Sciences Registration Date

19-Jul-94

Category / Sub-Category of Claris Life Sciences

Company limited by Shares

Claris Life Sciences Limited Registered Office Address

Coporate Towers" Nr. Parimal, Crossing, Ellisbridge, Ahemdabad - 380006

Claris Life Sciences Limited Registrar & Transfer Agent Address and Contact Details

Link InTime India Private Limited C 101, 247 Park, 1st Floor L.B.S. Marg, Vikhroli West, Mumbai - 400083, Tel. No.: 022 - 49186270

PARTICULAR OF SUBSIDIARY COMPANIES of Claris Life Sciences Limited

S. No.

Name of the Company

Subsidiary

% of shares held

 

                                 Foreign Subsidiaries

   

1.

Claris Life Sciences Venezuela C.A.

Subsidiary

100%

2.

PT. Claris Life Sciences Indonesia

Subsidiary

100%

BOARD OF DIRECTORS

Mr. Surrinder Lal Kapur (Chairman  &  Non-Executive and Independent Director)

Mr. Arjun Handa (Vice-Chairman & Managing Director)

Mr. Aditya S. Handa (Non-Executive and Non-Independent Director)

Mr. Chandrasingh S. Purohit (Whole Time Director & CFO)

Mr. Shyamsunder  Sharma (Non-Executive and Non-Independent Director)

Dr. Anup P. Shah (Non-Executive and Independent Director)

 SHAREHOLDING PATTERN (As of 31-03-2021) of Claris Life Sciences Limited

S. No.

Shareholder’s Name

No. of Shares

% of total Shares of the company

1

Promoter and Promoters Group

5,41,80,079

99.28%

2

Public

3,87,686

0.72%

 

Total

5,45,67,765

100%

 

 PROFIT & LOSS STATEMENT OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs) (As of 31-03-2018 to 31-03-2021)

PARTICULARS

2021

2020

2019

2018

INCOME

   

 

 

Other income

4.13

45.92

762.61

1,391.78

Total income

4.13

45.92

762.61

1,391.78

EXPENSES

   

 

 

Finance costs

0.04

0.22

-

-

Other expenses

31.39

145.49

1,246.98

1,793.80

Depreciation and amortization expense

-

-

-

10.31

Total expenses

31.43

145.71

1,246.98

1,804.11

Profit/(Loss) before tax

(27.30)

(99.79)

(484.37)

(412.33)

Tax expense / (benefit)

   

 

 

    Adjustment of tax relating to earlier years

-

(26.92)

-

449.77

    Deferred tax expense

-

428.37

264.70

(278.63)

    Current tax

-

         -

-

-

Total tax expense / (benefit)

-

401.45

264.70

171.14

Profit/(Loss) for the year from continuing operations

-

-

(749.07)

(583.47)

Profit before sharing in loss of Associate and tax from Discontinued operations

-

-

-

3,249.82

Tax Expenses of Discontinued operations

-

-

-

1,110.18

Net Profit / (Loss) for the year from discontinued operations

-

-

-

2,139.64

Profit / (Loss) for the year

(27.30)

(501.24)

(749.07)

1,556.17

Other comprehensive income

   

 

 

Items that will be reclassified to profit and loss

   

 

 

       Exchange differences in translating the financial statements of a

       foreign operation

-

-

41.04

0.08

       Income tax effect on above

-

-

-

-

Total comprehensive income / (loss) for the year

(27.30)

(501.24)

(708.02)

1,556.25

Profit for the year from continuing operations attributable to :

   

 

 

       Owners of the company

-

-

(749.07)

(583.47)

       Non-controlling interest

-

-

-

-

 

-

-

(749.07)

(583.47)

Profit for the year from discontinued operations attributable to :

   

 

 

        Owners of the company

-

-

-

2,283.19

        Non-controlling interest

-

-

-

(143.55)

 

-

-

-

2,139.64

Profit / (Loss) for the year attributable to :

   

 

 

        Equity holders of the parent

(27.30)

(501.24)

-

-

        Owners of the company

-

-

(749.07)

1,699.72

        Non-controlling interest

-

-

-

(143.55)

 

(27.30)

(501.24

(749.07)

1,556.17

Other comprehensive income/(loss) for the year attributable to

   

 

 

        Equity holders of the parent

-

-

-

-

        Owners of the company

-

-

41.04

5.51

        Non-controlling interest

-

-

-

(5.43)

 

-

-

41.04

0.08

Total comprehensive income / (loss) for the year, net of tax

   

 

 

       Equity holders of the parent

(27.30)

(501.24)

-

-

       Owners of the company

-

-

(708.02)

1,705.23

       Non-controlling interest

-

-

-

(148.98)

 

(27.30)

(501.24)

(708.02)

1,556.25

Earnings per equity share of Rs.10 each

   

 

 

      Earnings per equity share (Basic)

(0.05)

(0.92)

-

-

      Earnings per equity share (Diluted)

(0.05)

(0.92)

-

-

      Continuing Operations

-

-

(1.37)

(1.07)

      Discontinued Operations

-

-

-

4.18

Continuing & Discontinued Operations

-

-

(1.37)

3.11

 BALANCE SHEET OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs) (As of 31-03-2018 to 31-03-2021)

PARTICULARS

2021

2020

2019

2018

ASSETS

   

 

 

Non-current assets

   

 

 

Deferred tax assets (net)

527.85

527.85

956.21

1,220.91

Income tax assets (net)

104.89

104.78

-

-

Non-current tax assets (net)

-

-

634.64

626.74

Property, plant, and equipment

-

-

-

-

Capital work-in-progress

-

-

-

-

Intangible assets

-

-

-

-

Financial assets

   

 

 

     Investments

-

-

-

-

TOTAL

632.74

632.63

1,590.85

1,847.65

Current assets

   

 

 

Financial assets

   

 

 

      Trade receivables

-

-

62.68

58.10

      Cash and cash equivalents

11.63

18.11

27.43

6.88

      Other bank balances

36.02

38.87

38.38

31.60

      Other financial assets

258.76

269.69

341.95

131.62

Other current assets

39.44

39.18

111.98

326.89

TOTAL CURRENT ASSETS

345.85

365.85

582.42

555.09

TOTAL ASSETS

978.59

998.48

2,173.27

2,402.74

EQUITY AND LIABILITIES EQUITY

   

 

 

Equity share capital

5,456.78

5,456.78

5,456.78

5,456.78

Other Equity

(6,622.90)

(6,595.60)

(6,094.36)

(5,386.34)

TOTAL EQUITY

(1,166.12)

(1,138.82)

(637.58)

70.44

LIABILITIES

   

 

 

Current liabilities

   

 

 

Financial liabilities

   

 

 

      Borrowings

2,101.30

2,097.30

-

-

      Trade payables

   

 

 

        Total outstanding dues of micro-enterprises

        and small enterprises

0.54

-

-

-

       Total outstanding dues of creditors other than

       micro-enterprises and small enterprises

34.86

25.04

24.56

192.04

    Other financial liabilities

4.88

12.43

2,783.91

2,003.68

Other current liabilities

3.13

2.53

2.38

136.58

TOTAL CURRENT LIABILITIES

2,144.71

2,137.30

2,810.85

2,332.30

TOTAL EQUITY AND LIABILITIES

978.59

998.48

2,173.27

2,402.74

 

DIVIDEND AND RETAINED EARNINGS (As of 31-03-2018 to 31-03-2019) of Claris Life Sciences Limited

Particulars

2021

2020

2019

2018

Dividend

Nil

Nil

Nil

Nil

Retained Earnings (In Rs. Lakhs)

(6,622.90)

(6,595.60)

(6,181.03)

(5,431.96)

 PERFORMANCE OF Claris Life Sciences Limited

Income decreased from Rs. 45.92 Lacs in FY 2020 to Rs. 4.13 Lacs in FY 2021, showing a decline of 91.01% as compared to the previous financial year.

Finance Cost has decreased from Rs. 0.22 Lacs in FY 2020 to Rs.  0.04 Lacs in FY 2021.

In FY 2021, Company’s Net Loss stood at Rs. 27.30 Lacs,  as against the Rs. 501.24 Lakh loss in FY 2020.

The Current Ratio of the company as of 31st March 2021 was 0.16%.

 The debt-to-equity ratio of the company as of 31st March 2021 was 0.83%.

In the Financial Year 2020-21, the company has not paid dividends.

FAQs

Q1: What is the claris-life-sciences-limited share price?

A1: Claris life sciences limited share price is not fixed, it keeps changing daily.

Q2: Who is the CEO of Claris Lifesciences?

A2: Arjun Handa is the CEO of  Claris Life Sciences Limited.

Q3: What factors are affecting claris-life-sciences-limited share price?

A3: Claris life sciences limited share price can be affected by various factors such as changes in the company's financial performance, industry trends, regulatory changes, and global economic conditions.

 

Annual Report

Claris Life Sciences Annual Report 2020-21

Download

Claris Life Sciences Annual Report 2019-20

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha